KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Operating Expenses (2018 - 2025)

Historic Operating Expenses for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $7.0 million.

  • ClearPoint Neuro's Operating Expenses rose 901.49% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.3 million, marking a year-over-year increase of 2230.0%. This contributed to the annual value of $24.4 million for FY2024, which is 394.2% up from last year.
  • As of Q3 2025, ClearPoint Neuro's Operating Expenses stood at $7.0 million, which was up 901.49% from $7.2 million recorded in Q2 2025.
  • Over the past 5 years, ClearPoint Neuro's Operating Expenses peaked at $7.5 million during Q1 2025, and registered a low of $3.2 million during Q1 2021.
  • Over the past 5 years, ClearPoint Neuro's median Operating Expenses value was $5.4 million (recorded in 2023), while the average stood at $5.7 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 10192.5% in 2021, then tumbled by 1334.22% in 2024.
  • Over the past 5 years, ClearPoint Neuro's Operating Expenses (Quarter) stood at $5.0 million in 2021, then grew by 5.85% to $5.3 million in 2022, then increased by 1.3% to $5.4 million in 2023, then rose by 22.95% to $6.6 million in 2024, then increased by 6.56% to $7.0 million in 2025.
  • Its Operating Expenses stands at $7.0 million for Q3 2025, versus $7.2 million for Q2 2025 and $7.5 million for Q1 2025.